TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20923529

Group type: EXPERIMENTAL
Intervention: Carbohydrate-rich diet (>70% carbohydrate)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Control diet (<70% carbohydrate)
Number of subjects: 320
Study: 17714607

Group type: EXPERIMENTAL
Intervention: Ciclesonide 160 microg once daily (CIC160 OD)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Fluticasone propionate 250 microg twice daily (FP250 BID)
Number of subjects: 111
Study: 12920059

Group type: EXPERIMENTAL
Intervention: CCK octapeptide (CCK-8; 112 ng/min for 23 min) with gastric distension (300 ml)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline infusion with gastric distension (300 ml)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: CCK octapeptide (CCK-8; 112 ng/min for 23 min) without gastric distension
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline infusion without gastric distension
Number of subjects: 8

Group type: COMPARATOR
Intervention: Gastric distension (300 ml) without CCK
Number of subjects: 8
Study: 11938830

Group type: EXPERIMENTAL
Intervention: Xiangsha Yangwei pill (XSYW)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Moxibustion
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Motilium
Number of subjects: 60

Group type: COMPARATOR
Intervention: Spine Surgery (SpS)
Number of subjects: 60
Study: 9437628

Group type: EXPERIMENTAL
Intervention: Cognitively enhanced counseling
Number of subjects: 527

Group type: COMPARATOR
Intervention: Standard counseling
Number of subjects: 527
Study: 8265515

Group type: EXPERIMENTAL
Intervention: ICI 169,369 30 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: ICI 169,369 120 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 2869848

Group type: EXPERIMENTAL
Intervention: nadolol
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: metoprolol
Number of subjects: 44
Study: 28224445

Group type: EXPERIMENTAL
Intervention: Skills training app
Number of subjects: 186

Group type: COMPARATOR
Intervention: Skills training app (men)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Skills training app (women)
Number of subjects: 186
Study: 24933175

Group type: EXPERIMENTAL
Intervention: Sequential photo lineup procedure
Number of subjects: 494

Group type: COMPARATOR
Intervention: Simultaneous photo lineup procedure
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Both procedures (simultaneous and sequential)
Number of subjects: 494
Study: 23404735

Group type: EXPERIMENTAL
Intervention: High-Intensity Treatment (HIT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-Intensity Treatment (LIT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No Intervention
Number of subjects: 0
Study: 21316861

Group type: EXPERIMENTAL
Intervention: Client statements indicating desire and reasons for change
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Commitment language
Number of subjects: 61
Study: 19563454

Group type: EXPERIMENTAL
Intervention: Increase in total carbohydrate intake by 1 E%
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Increase in sucrose intake by 1 E%
Number of subjects: 644
Study: 19131303

Group type: EXPERIMENTAL
Intervention: Lecture training group
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Video training group
Number of subjects: 297
Study: 15458799

Group type: EXPERIMENTAL
Intervention: Low-intensity exercise (cycling at 50% of peak oxygen uptake)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: High-intensity exercise (cycling at 75% of peak oxygen uptake)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sedentary condition
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: High-intensity exercise
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Low-intensity exercise
Number of subjects: 19
Study: 11842709

Group type: EXPERIMENTAL
Intervention: Home management (acute care at home)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Hospital management
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Home management
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 25
Study: 9150288

Group type: EXPERIMENTAL
Intervention: Electrical pain stimulus
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control stimulus
Number of subjects: 24
Study: 7963282

Group type: EXPERIMENTAL
Intervention: Remembering word-and-background pairs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Remembering words
Number of subjects: 0
Study: 3307499

Group type: EXPERIMENTAL
Intervention: Oral fructose mineral drink
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 25
Study: 30562555

Group type: EXPERIMENTAL
Intervention: Task-specific training on the functional reaching task (3 days, 150 trials)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Functional reaching training
Number of subjects: 90

Group type: COMPARATOR
Intervention: No training
Number of subjects: 90
Study: 28530532

Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy for 8 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 25761837

Group type: EXPERIMENTAL
Intervention: Caffeine (75 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Caffeine (75 mg) + L-theanine (50 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: L-theanine (50 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 23922133

Group type: EXPERIMENTAL
Intervention: Picking or nibbling (P&N) behavior in binge eating disorder (BED)
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Picking or nibbling (P&N) behavior in bulimia nervosa (BN)
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Picking or nibbling (P&N) behavior in anorexia nervosa (AN)
Number of subjects: 660

Group type: COMPARATOR
Intervention: Association of P&N with BMI, compensatory behaviors, binge eating, or eating disorder examination subscales
Number of subjects: 660
Study: 21114493

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri DSM 17938 at a dose of 1 × 10(8) CFU per day for 30 days
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 19168109

Group type: EXPERIMENTAL
Intervention: HEV 239 vaccine
Number of subjects: 612
Study: 16715641

Group type: EXPERIMENTAL
Intervention: 100% Knowledge of Results (KR)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 50% Knowledge of Results (KR)
Number of subjects: 16
Study: 14769686

Group type: EXPERIMENTAL
Intervention: sirolimus‐eluting stent
Number of subjects: 1058

Group type: COMPARATOR
Intervention: Control bare stent
Number of subjects: 1058
Study: 11712878

Group type: EXPERIMENTAL
Intervention: Physicians' willingness to perform actions disallowed by the American Medical Association
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Physicians' willingness to perform five or more disallowed actions
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Correlation with perceived duty to society
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Correlation with approval of the death penalty
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Correlation with approval of assisted suicide
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Knowledge of guidelines on physician participation in capital punishment
Number of subjects: 1000
Study: 9486881

Group type: EXPERIMENTAL
Intervention: Laparoscopic exploration
Number of subjects: 18

Group type: COMPARATOR
Intervention: Traditional exploration
Number of subjects: 18
Study: 7528299

Group type: EXPERIMENTAL
Intervention: nitrendipine (10‐20 mg b.i.d.)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: captopril (25‐50 mg b.i.d.)
Number of subjects: 48
Study: 3053569

Group type: EXPERIMENTAL
Intervention: Spiramycin tablets for 5 1/2 days
Number of subjects: 221

Group type: COMPARATOR
Intervention: Doxycycline tablets for nine days
Number of subjects: 221
Study: 30111495

Group type: EXPERIMENTAL
Intervention: Active commercial breaks (ACBs) - prolonged sitting interrupted every 20 min with 3 min of light-intensity body-weight resistance activities
Number of subjects: 9

Group type: COMPARATOR
Intervention: SIT - prolonged sitting during TV viewing
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Active commercial breaks (ACBs)
Number of subjects: 9

Group type: COMPARATOR
Intervention: SIT
Number of subjects: 9
Study: 28072987

Group type: EXPERIMENTAL
Intervention: Monolithic lithium disilicate (LS2) crown produced by CEREC (CER group)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Manually fabricated resin crown utilizing conventional workflow (CONV group)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: CER group
Number of subjects: 13

Group type: COMPARATOR
Intervention: CONV group
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Overall survival rate
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Screw loosening
Number of subjects: 13
Study: 24998770

Group type: EXPERIMENTAL
Intervention: Plasma rich in growth factors (PRGF)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Blood clot (Control)
Number of subjects: 60
Study: 23742789

Group type: EXPERIMENTAL
Intervention: Prenotification package
Number of subjects: 367

Group type: COMPARATOR
Intervention: Direct questionnaire mailing
Number of subjects: 367
Study: 21397253

Group type: EXPERIMENTAL
Intervention: Active HF-rTMS (n = 22)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sham rTMS (n = 22)
Number of subjects: 44
Study: 19632716

Group type: EXPERIMENTAL
Intervention: Concurrent induction chemotherapy (two cycles of cisplatin [50 mg/m(2) on days 1, 8, 29, and 36] and etoposide [50 mg/m(2) on days 1‐5 and 29‐33]) plus radiotherapy (45 Gy) followed by surgical resection if no progression.
Number of subjects: 396

Group type: COMPARATOR
Intervention: Standard concurrent chemotherapy and definitive radiotherapy without resection (up to 61 Gy).
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Concurrent induction chemotherapy plus radiotherapy followed by surgical resection.
Number of subjects: 396

Group type: COMPARATOR
Intervention: Standard concurrent chemotherapy and definitive radiotherapy without resection.
Number of subjects: 396
Study: 16541859

Group type: EXPERIMENTAL
Intervention: Acupuncture kinetotherapy (Acupuncture at Kaiyin point No. 1 combined with deep respiratory movement of the glottis), once daily for 5 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Ultrasonic aerosol inhalation of 0.9% sodium chloride injection, gentamicin sulfate injection 80,000 U and Dexamethasone injection 5mg, twice a day for 5 days
Number of subjects: 80
Study: 15553817

Group type: EXPERIMENTAL
Intervention: Shuxuetong (SXT)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control
Number of subjects: 68
Study: 11091827

Group type: EXPERIMENTAL
Intervention: Bipolar electrodissection technique
Number of subjects: 70

Group type: COMPARATOR
Intervention: Dissection ligation technique
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 70
Study: 9075040

Group type: EXPERIMENTAL
Intervention: Intravenous clonidine 3 micrograms/kg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Oral clonidine 4 micrograms/kg
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 1783695

Group type: EXPERIMENTAL
Intervention: Nitrous oxide sedation
Number of subjects: 56

Group type: COMPARATOR
Intervention: Behavioral management only (control)
Number of subjects: 56
Study: 7050341

Group type: EXPERIMENTAL
Intervention: Johnson and Johnson unwaxed dental floss
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Waxed dental floss
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (other types of dental floss)
Number of subjects: 80
Study: 31653518

Group type: EXPERIMENTAL
Intervention: Low-phosphorus diet
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Normal phosphorus diet
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High-altitude exposure
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Combined exercise and high-altitude exposure
Number of subjects: 8
Study: 30014865

Group type: EXPERIMENTAL
Intervention: High flavonoid cocoa drink (350 mg gallic acid equivalents {GAE}/g)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low flavonoid cocoa control (120 mg GAE/g)
Number of subjects: 12
Study: 26977123

Group type: EXPERIMENTAL
Intervention: Yoga Skills Training (YST)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Attention Control (AC)
Number of subjects: 15
Study: 23571810

Group type: EXPERIMENTAL
Intervention: ABT‐925 150 mg
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: ABT‐925 50 mg
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study: 20974485

Group type: EXPERIMENTAL
Intervention: Viewing the procedure on a video monitor (Group A)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 76
Study: 18844328

Group type: EXPERIMENTAL
Intervention: Yamabushitake (Hericium erinaceus) - 250 mg tablets, 4 tablets three times a day for 16 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 16429088

Group type: EXPERIMENTAL
Intervention: Adolescent patients with conduct disorder and substance use disorder
Number of subjects: 20

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 20
Study: 14970979

Group type: EXPERIMENTAL
Intervention: Interferential current (IFC) at 0 Hz
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Interferential current (IFC) at 5 Hz
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Interferential current (IFC) at 100 Hz
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Transcutaneous electric nerve stimulation (TENS) at 5 Hz
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Transcutaneous electric nerve stimulation (TENS) at 100 Hz
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo stimulation
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control stimulation
Number of subjects: 140
Study: 11741100

Group type: EXPERIMENTAL
Intervention: Cabergoline, a long-acting dopamine agonist, dosage and duration not specified
Number of subjects: 0

Group type: COMPARATOR
Intervention: Levodopa, a dopaminergic agent, dosage and duration not specified
Number of subjects: 0
Study: 9682673

Group type: EXPERIMENTAL
Intervention: Half-dose aprotinin (Group 2)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Full-dose aprotinin (Group 3)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cytomix alone (control group)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Aprotinin (in vitro)
Number of subjects: 30
Study: 8161288

Group type: EXPERIMENTAL
Intervention: Oral fluphenazine hydrochloride (5 mg twice daily)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 2961624

Group type: EXPERIMENTAL
Intervention: Danazol
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Surgical elimination of endometriosis
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 29669963

Group type: EXPERIMENTAL
Intervention: Remote Ischemic Preconditioning (RIPC)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Control
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Intravenous Nicorandil
Number of subjects: 171
Study: 27549626

Group type: EXPERIMENTAL
Intervention: Infection-primed group (IP)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Vaccine-primed group (VP)
Number of subjects: 80
Study: 25681720

Group type: EXPERIMENTAL
Intervention: ODTs containing core granules
Number of subjects: 0

Group type: COMPARATOR
Intervention: ODTs containing placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Core granules with particle sizes ≥ 200 μm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ODTs with coated core granules
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Core granules composed of water-soluble additives
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Threshold particle size of core granule
Number of subjects: 0
Study: 22592447

Group type: EXPERIMENTAL
Intervention: Harm to self (HTS) counseling intervention
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Harm to others (HTO) counseling intervention
Number of subjects: 40
Study: 20588019

Group type: EXPERIMENTAL
Intervention: Postconditioning during primary angioplasty (PA) and stenting
Number of subjects: 78

Group type: COMPARATOR
Intervention: Plain primary angioplasty (PA) without postconditioning
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Postconditioning
Number of subjects: 78
Study: 18371483

Group type: EXPERIMENTAL
Intervention: High-dose statin therapy
Number of subjects: 4178

Group type: EXPERIMENTAL
Intervention: Estimated GFR <60 mL/min
Number of subjects: 4178

Group type: EXPERIMENTAL
Intervention: CRP in the fourth quartile
Number of subjects: 4178
Study: 16618300

Group type: EXPERIMENTAL
Intervention: Early administration of tropisetron (0.1 mg x kg(‐1), max 2 mg) immediately after inhalational induction
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Late administration of tropisetron (0.1 mg x kg(‐1), max 2 mg) after the end of surgery before extubation
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Late administration of tropisetron
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Early administration of tropisetron
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both early and late administration of tropisetron
Number of subjects: 120
Study: 12788301

Group type: EXPERIMENTAL
Intervention: Nurse-led heart failure clinic follow-up
Number of subjects: 106
Study: 11007220

Group type: EXPERIMENTAL
Intervention: Cisapride 10 mg t.i.d. for 30 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo t.i.d. for 30 days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cisapride
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 8831847

Group type: EXPERIMENTAL
Intervention: Lysate from cultured allogeneic keratinocytes
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (antibiotic suspension only)
Number of subjects: 50
Study: 8173689

Group type: EXPERIMENTAL
Intervention: Fixed combination of felodipine plus metoprolol 5/50‐10/100 mg (FM)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Felodipine 5‐10 mg (F)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Metoprolol 50‐100 mg (M)
Number of subjects: 58
Study: 3527886

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LH); n = 29
Number of subjects: 56

Group type: COMPARATOR
Intervention: Unfractionated heparin (UH); n = 27
Number of subjects: 56
Study: 29654053

Group type: EXPERIMENTAL
Intervention: Silver diamine fluoride and fluoride varnish
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluoride varnish and glass ionomer therapeutic sealants
Number of subjects: 0
Study: 27189681

Group type: EXPERIMENTAL
Intervention: Caffeine citrate (25 mg/kg, intravenous, single dose)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Saline placebo (single dose)
Number of subjects: 90
Study: 24059690

Group type: EXPERIMENTAL
Intervention: Nebivolol 5 mg once daily
Number of subjects: 138

Group type: COMPARATOR
Intervention: Atenolol 50 mg once daily (titrated to 100 mg for non-responders)
Number of subjects: 138
Study: 23420326

Group type: EXPERIMENTAL
Intervention: Medication group (group M) treated with pioglitazone
Number of subjects: 24

Group type: COMPARATOR
Intervention: Gallstone group (group G)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Normal control group (group C)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Human cholesterol gallstone patients
Number of subjects: 24

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 24
Study: 19477733

Group type: EXPERIMENTAL
Intervention: Exercise (walking on a treadmill for 60 min at 65% age‐predicted maximum heart rate)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Rest
Number of subjects: 80
Study: 18975365

Group type: EXPERIMENTAL
Intervention: Vitamin E (600 IU every other day)
Number of subjects: 39144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39144
Study: 16324915

Group type: EXPERIMENTAL
Intervention: Glimepiride + 4 mg rosiglitazone
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Glimepiride + 8 mg rosiglitazone
Number of subjects: 102

Group type: COMPARATOR
Intervention: Glimepiride + placebo
Number of subjects: 102
Study: 14653829

Group type: EXPERIMENTAL
Intervention: Artichoke leaf extract (ALE) 2 x 320 mg plant extract t.d.s.
Number of subjects: 247

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Artichoke leaf extract (ALE)
Number of subjects: 247
Study: 10988190

Group type: EXPERIMENTAL
Intervention: Supplemental Oxygen (SuppO2)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Compressed Air (CA)
Number of subjects: 51
Study: 8971428

Group type: EXPERIMENTAL
Intervention: Theophylline (loading dose 5 mg kg‐1 over 20 min, followed by 0.5 mg kg‐1 min‐1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dipyridamole (0.21 mg kg‐1 h‐1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl)
Number of subjects: 0
Study: 1317691

Group type: EXPERIMENTAL
Intervention: Thiorphan (2.5 mg/ml, 0.5 ml)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 6742538

Group type: COMPARATOR
Intervention: Flunitrazepam (0.33 mg X kg‐1)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Midazolam (0.3 mg X kg‐1)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Midazolam (0.4 mg X kg‐1)
Number of subjects: 75
Study: 30875090

Group type: EXPERIMENTAL
Intervention: Intravenous Oxycodone
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intravenous Sufentanil
Number of subjects: 100
Study: 29052102

Group type: EXPERIMENTAL
Intervention: Neuro Emotional Technique (NET) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 0
Study: 27741166

Group type: EXPERIMENTAL
Intervention: Bifidobacterium breve B632 and BR03; 5 drops of active product (10 viable cells/strain) for 90 days
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo; 5 drops of placebo for 90 days
Number of subjects: 23
Study: 24780450

Group type: EXPERIMENTAL
Intervention: Tight glycaemic control (TGC): insulin by intravenous infusion titrated to maintain blood glucose between 4.0 and 7.0 mmol/l.
Number of subjects: 1369

Group type: COMPARATOR
Intervention: Conventional management (CM): insulin by intravenous infusion only if blood glucose exceeded 12.0 mmol/l on two samples at least 30 minutes apart; insulin was stopped when blood glucose fell below 10.0 mmol/l.
Number of subjects: 1369